Boston Scientific Invests $1.5B in MiRus, Secures Option to Acquire Its TAVR Technology
Boston Scientific has invested $1.5 billion in Georgia‑based medtech company MiRus, acquiring a roughly 34% equity stake and an exclusive option to fully purchase MiRus’s Siegel TAVR technology for up to $3 billion pending regulatory milestones. The strategic investment bolsters Boston Scientific’s structural‑heart portfolio after it discontinued its own TAVR valves.
Cellogen Therapeutics Raises $2M From Kotak Alternate Asset Managers
Biotech startup Cellogen Therapeutics secured ₹20 Cr (≈$2 M) in funding from Kotak Alternate Asset Managers via its Kotak Life Sciences Fund I. The capital will support the company’s CAR‑T clinical programmes, gene‑therapy pipeline, and GMP‑compliant manufacturing and regulatory capabilities.
Embecta Closes Owen Mumford Acquisition for up to $201M
Embecta completed its acquisition of Owen Mumford Holdings, paying up to £150 million (≈$201 million) in cash and performance‑based payments. The deal expands Embecta’s portfolio beyond diabetes products into broader medical supplies, leveraging Owen Mumford’s auto‑injector technology. The transaction closed on Friday,...
Tecomet Merges with Orchid Orthopedic Solutions
Tecomet, backed by Charlesbank, and Orchid Orthopedic Solutions, backed by Nordic, have completed a merger, with the combined entity operating under the Tecomet name. The transaction consolidates the orthopedic solutions businesses under a single brand.
Aumet Raises $12M Series A Led by Emkan Capital
Saudi Arabia-based healthtech Aumet announced the close of a $12 million Series A round, led by Emkan Capital and joined by Qatar Development Bank, SABAH Fund, AAIC, Shorooq Partners, Right Side Capital Management, Cigalah Group and Salehiya Trading Company. The...
IKS Health Acquires ARAI Solutions to Build Full Agentic AI Stack for Healthcare
IKS Health announced the acquisition of ARAI Solutions, a specialist AI provider, to create a full agentic AI stack for healthcare. The deal enables IKS Health to develop proprietary small language models and integrate biomedical knowledge graphs, reducing reliance on...
Anthropic Secures $200M Grant Partnership with Gates Foundation
Anthropic announced a partnership with the Gates Foundation that includes $200 million in grant funding, Claude usage credits, and technical support for programs in global health, life sciences, education, and economic mobility over the next four years. The collaboration aims...
Signant Health Acquires Ametris to Combine Wearable Data and eCOA Technology
Signant Health announced the acquisition of Ametris, a wearable measurement company formerly known as ActiGraph, to integrate eCOA technology with wearable data. Financial terms were undisclosed. The combined platform aims to streamline clinical trial data collection for pharmaceutical sponsors.
CREATE Medicines Raises $122M in New Funding Round
Biotech firm CREATE Medicines, formerly Myeloid Therapeutics, announced it has raised $122 million from investors Newpath Partners, ARCH Venture Partners, and Hatteras Venture Partners to advance its CAR‑T therapy pipeline. The funding will support human trials for its first CAR‑T...
Shyld AI Secures $13.4M to Scale Agentic AI and Autonomous Disinfection Across U.S. Health Systems
Shyld AI, a healthcare AI startup, closed a $13.4 million seed round led by Aulis Capital to expand its agentic AI and autonomous UV‑C disinfection technology across U.S. health systems. The funding will support scaling of its edge‑native VERTEX platform and...
CVS Health's Omnicare Sale to GenieRx Approved by Bankruptcy Court
CVS Health announced that its long-term care pharmacy subsidiary Omnicare has received court approval for its sale to GenieRx Holdings LLC, a partnership of Milrose Capital and Integro Healthcare Services. The deal, with undisclosed terms, is expected to close later...
Knit Health Raises $11.6M for Fundamentally Different Approach to Healthcare AI
Knit Health, a UC Berkeley spin‑out focused on AI‑driven healthcare operations, announced a $11.6 million fundraising round. The capital will support the development of its AI platform that mimics doctors' decision‑making. The round underscores growing investor interest in AI‑enabled health tech...
Enhabit Shareholders Approve $1.1B Kinderhook Acquisition
Enhabit Inc. shareholders approved the sale of the home‑health provider to private‑equity firm Kinderhook Industries for $1.1 billion, paying $13.80 per share in cash. The deal, first announced three months ago, will take Enhabit private and is expected to close soon...
Doctor Care Anywhere Acquires Outcome Diagnostics Limited and Medic Spot Limited for $1.08M
Doctor Care Anywhere announced the acquisition of UK weight-management firms Outcome Diagnostics Limited and Medic Spot Limited for £850,000 (≈$1.08 million). The purchase expands Doctor Care Anywhere's GLP-1 capabilities and cross-selling opportunities across its virtual GP, mental health, physiotherapy, and...
Pfizer and Arvinas Sell Breast Cancer Drug Rights to Rigel for $35M
Pfizer and its partner Arvinas have sold the rights to their recently approved breast cancer drug to Rigel Pharmaceuticals for $35 million, a steep drop from the $1 billion invested in development.
Bristol Myers Squibb Signs $15.2B Licensing Deal with China's Hengrui Pharma
On May 12, 2026, Bristol Myers Squibb announced a global strategic collaboration with Hengrui Pharma to license 13 early‑stage oncology, hematology and immunology assets. The deal includes $600 million upfront and up to $15.2 billion in total value, granting BMS exclusive ex‑China...
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy
Cellular Intelligence, backed by Mark Zuckerberg, announced the acquisition of Novo Nordisk's Parkinson's disease cell therapy candidate STEM‑PD. Financial terms were undisclosed, with Novo Nordisk taking an equity stake and potential milestone payments. The deal will leverage Cellular's AI platform...
Lexicon Pharmaceuticals Secures $100M Loan Facility From Hercules Capital
Lexicon Pharmaceuticals announced a new $100 million loan facility from Hercules Capital, bolstering its balance sheet with $199.7 million in cash and investments. The financing comes as the company reports Q1 2026 revenue of $21.1 million, driven by milestones from...
Stryker Completes Acquisition of Amplitude Vascular Systems
Stryker has completed its acquisition of Amplitude Vascular Systems, the developer of the Pulse intravascular lithotripsy platform for treating severely calcified arterial disease. Financial terms were not disclosed. The deal expands Stryker's peripheral vascular portfolio with IVL technology.
CareTrust REIT Closes $865M in Nursing Home Acquisitions in April
CareTrust REIT announced that it completed 12 transactions in April, acquiring skilled nursing and senior housing assets for roughly $865 million. The acquisitions, primarily U.S. skilled nursing properties, were closed at a blended stabilized yield of about 8.9%, bringing the REIT’s...
Stillwater Hospice to Acquire Campbell County Health Hospice
Montana‑based Stillwater Hospice announced it will acquire Wyoming’s Campbell County Health Hospice for an undisclosed sum, with the transaction effective June 1. The acquisition aims to expand clinical resources and support services while preserving CCH’s community roots. No service interruptions are...
Scarlet Therapeutics Raises £3.2M Seed Round to Advance Lab‑grown Red Blood Cell Therapies
Scarlet Therapeutics, a UK biotech developing lab‑grown red blood cell therapies, announced a seed round of £3.2 million (≈$4.1 million) led by Eos Advisory, with participation from Oshen Bio, Daft Capital and existing backer SCVC. The funding will support pre‑clinical studies, animal...
Knox Lane to Acquire Cross Country Healthcare in $437M Cash Deal
Private equity firm Knox Lane announced a merger agreement to acquire healthcare staffing provider Cross Country Healthcare in an all‑cash transaction valued at $437 million, paying $13.25 per share, a 31% premium. The deal was disclosed on May 7 2026 and is expected...
Kanvas Biosciences Secures $48M Series A Funding Co-Led by DCVC and Lions Capital
Kanvas Biosciences announced a $48M Series A round co-led by DCVC and Lions Capital LLC, bringing its total funding to $78M. The capital will support clinical trials for its immuno‑oncology candidate KAN‑001 and further development of its spatial biology platform....
Angelini Pharma Agrees to Acquire Catalyst Pharma for up to $4.1B
Italy's Angelini Pharma announced it will acquire US‑listed Catalyst Pharma for up to $4.1 billion, paying $31.50 per share (a 28% premium). The acquisition gives Angelini three FDA‑approved neuromuscular and epilepsy products and marks its entry into the US market. The...
InflaRx Raises $150M in US Public Offering to Fund Kidney Drug Development
InflaRx N.V., a Nasdaq‑listed German biotech, announced a US$150 million public offering of 75 million shares at $2.00 each to fund development of its oral C5aR inhibitor izicopan for severe renal diseases, including ANCA‑associated vasculitis. The financing attracted existing and new institutional...
Gilead Sciences to Acquire Tubulis, Adding ADC Platform to Oncology Pipeline
Gilead Sciences announced a definitive agreement to acquire Tubulis, a Germany‑based clinical‑stage biotech focused on antibody‑drug conjugates. The transaction includes Tubulis’ lead ADC candidate TUB‑040, currently in Phase I/IIa trials for platinum‑resistant ovarian cancer and non‑small cell lung cancer. Financial...
Vigilance Santé Acquires MedSafer to Expand Medication Decision-Support Capabilities
Canadian clinical decision support leader Vigilance Santé announced the acquisition of Quebec-based MedSafer, a developer of deprescribing tools. The undisclosed deal will integrate MedSafer’s validated solutions into Vigilance’s portfolio, strengthening its medication management offerings for healthcare professionals.
Rosarium Health Raises $6M Seed Funding Led by Kalos Ventures
Rosarium Health, a platform enabling in‑home assessments and modifications for aging individuals, announced a $6 million seed round led by Kalos Ventures with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, American Family Insurance Institute, Black Tech Nations Ventures and The...
CareTria, Backed by Frazier Healthcare, Acquires Digital Pharmacy CaryHealth
CareTria, a therapy initiation partner to pharmaceutical companies, has completed the acquisition of digital pharmacy CaryHealth. The deal, backed by Frazier Healthcare, expands CareTria's digital health capabilities. The acquisition was announced on May 6, 2026.
Citius Oncology Secures $36.5M Debt and Equity Financing to Accelerate Lymphir Commercialisation
Citius Oncology announced it has secured up to $36.5 million in combined debt and equity financing to fund the commercial launch of its Lymphir immunotherapy. The financing includes a senior secured term loan of up to $25 million from Avenue...
CellCentric Secures $220M Series D Funding to Advance Multiple Myeloma Drug
CellCentric, a UK‑ and US‑based biotech, raised $220 million in a Series D round led by Venrock Healthcare Capital Partners, with participation from Pfizer, Fidelity Management & Research Company, Sofinnova Partners, RA Capital Management and Forbion. The capital will fund a Phase 3...
LeadingAge Massachusetts and LeadingAge Maine & New Hampshire Approve Regional Merger Across Four States
LeadingAge Massachusetts and LeadingAge Maine & New Hampshire have approved a merger to form a regional association covering Massachusetts, Maine, New Hampshire, and Vermont. The combined entity aims to strengthen advocacy and support for aging services providers, with operations slated...
Doctolib Completes Acquisition of Medicus Health to Enter UK Market
European digital health platform Doctolib completed the acquisition of UK‑based startup Medicus Health in May 2026, securing a foothold in the NHS primary‑care market. The deal, valued at an undisclosed amount, supports Doctolib’s strategy to expand into the UK ahead...
Bayer to Acquire Perfuse Therapeutics in $2.45B Deal
Bayer announced it will acquire ophthalmology-focused biotech Perfuse Therapeutics, paying $300 million upfront with total consideration potentially reaching $2.45 billion based on milestones. The acquisition adds Perfuse’s PER‑001 intravitreal implant for glaucoma and diabetic retinopathy to Bayer’s pipeline. The deal, announced on...
Strata Critical Medical Secures $30M Asset‑Based Credit Facility with J.P. Morgan
Strata Critical Medical Inc announced the closing of a $30 million asset‑based credit facility with J.P. Morgan. The undrawn facility provides financing flexibility and can be increased to $50 million. The deal was disclosed during the company's Q1 2026 earnings call.
Columna Capital to Acquire Evidenze Group From Buenavista Equity Partners
Columna Capital announced it will acquire Evidenze Group, a pan‑European outsourced pharma services platform, from its current owner Buenavista Equity Partners. The terms of the transaction were not disclosed. The deal was reported on May 5, 2026.
Madeed Raises $925K Pre‑seed to Scale Personalised Preventive Healthcare in Saudi Arabia
Saudi healthtech startup Madeed announced the closing of a $925,000 pre‑seed round, bringing its total funding to $925,000. The round was led by SEEDRA Ventures, Unity Investment Partners and Seen Growth, with participation from earlier investor Vision Ventures. The capital...
Spyre Therapeutics Raises $463M in Underwritten Public Offering
Spyre Therapeutics announced it raised $463 million in gross proceeds from an underwritten public offering of common stock, boosting its pro‑forma cash balance to $1.2 billion. The offering, completed in April 2026, provides runway into the second half of 2029 and supports the...
Goldman Sachs-Backed Xpress Wellness Acquires Midwest Counseling Services
Xpress Wellness, an Oklahoma City-based provider of urgent care, virtual primary care, occupational medicine, behavioral health and post‑acute services, has completed the acquisition of Midwest Counseling Services, expanding its behavioral health footprint in rural and suburban communities. The deal, backed...
Impact Advisors Acquires Canopii Collaborative to Expand Epic Payer and Tapestry Expertise
Impact Advisors, a healthcare management consulting firm, has acquired Canopii Collaborative, a consulting firm specializing in the Epic payer platform Tapestry and revenue cycle services. The acquisition enhances Impact Advisors' capabilities in payer‑side technology and “Payvider” transformation. Financial terms were...
UPMC to Acquire Trinity Health System From CommonSpirit Health
University of Pittsburgh Medical Center (UPMC) and CommonSpirit Health have signed a definitive agreement to transfer ownership of the Trinity Health System in Ohio, including several hospitals and clinics. The deal, pending regulatory approval, is expected to close in the...
Village Secures $9.5M Funding Led by Upfront Ventures to Expand AI‑Powered Pediatric Care Platform
Los Angeles‑based healthtech startup Village announced a $9.5 million funding round led by Upfront Ventures, with participation from Bling Capital, GTMFund and Perceptive Ventures. The capital will support the expansion of its AI‑driven coordinated care platform for pediatric specialty services across...
Mobia Medical Sets Terms for $150M IPO
Mobia Medical, a neurostimulation-device maker, announced it will raise about $150 million in an initial public offering, offering 10 million shares at $14‑$16 each and expecting net proceeds of $134.5 million (up to $155.4 million with the underwriters’ option). The proceeds will fund expansion...
Arete Health, Backed by MBF Healthcare, Acquires Virginia Rehabilitation & Wellness and Summerville Physical Therapy & Balance for Adults
Arete Health, a clinician-led outpatient physical therapy platform based in Coral Gables, Florida, announced the acquisition of Virginia Rehabilitation & Wellness and Summerville Physical Therapy & Balance for Adults. The transaction expands Arete Health’s service footprint in the adult physical...
Pediatrica Health Group Acquires Westchester Pediatric Practice in Miami
Miami‑based Pediatrica Health Group announced the acquisition of a Westchester pediatric primary‑care practice owned by Dr. Juan Ruiz‑Unger, expanding its multi‑site network. The deal, disclosed on May 5 2026, aims to increase equitable access to care for the growing community, with no...
Sigma Healthcare to Acquire 75% Stake in GreenLight UK Pharmacy Stores
Australian wholesaler Sigma Healthcare announced a joint venture with UK-based GreenLight Healthcare, acquiring a 75% stake in its 22-store pharmacy network and licensing the Chemist Warehouse brand. The rollout will start with up to five rebranded locations, including a flagship...
UCB Invests $2B in Candid's T‑cell Engager Program
UCB announced a $2 billion strategic investment in Candid, a European biotech developing T‑cell engager therapies for autoimmune diseases. The funding will accelerate Candid's research and development, expanding UCB's immunotherapy pipeline. The deal was confirmed on May 4 2026.
InspireMD Raises $58M in Private Placement and Warrant Exercises
InspireMD Inc entered a securities purchase agreement with institutional investors, raising $40.1 million in a private placement, and exercised warrants for $17.9 million, bringing total new capital to $58 million. The financing, disclosed in its Q1 2026 earnings call, will fund the U.S. commercial...
AI Diagnostics Raises $4.6M in Pre‑Series‑A Round Led by Steele Foundation for Hope
Cape Town‑based med‑tech startup AI Diagnostics announced it has closed a pre‑Series‑A funding round of R85 million (≈$4.6 million). The round was led by the Steele Foundation for Hope and will fund deployment of its AI‑powered digital stethoscope Ostium and expansion of...